Concepedia

Lori A. Ehrlich

LA

Statistics

Publications

11

Citations

862

H-Index

10

Active since

2000

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

The University of Texas at San Antonio Health Science Center

University of Pittsburgh

UPMC Hillman Cancer Center

Lori A. Ehrlich is an author at United States Food and Drug Administration specializing in medicine, oncology, and bone metabolism.

ORCID

Publications per year

2000–2023

11

Publications

11

IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells

Junwon Lee, Ho Yeon Chung, Lori A. Ehrlich et al. · Blood · 2003 · 236 citations · Full text

, , +16

IL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

Lori A. Ehrlich, Ho Yeon Chung, Irene M. Ghobrial et al. · Blood · 2005 · 204 citations

, , +16

MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells

Yasuo Oba, Junwon Lee, Lori A. Ehrlich et al. · Experimental Hematology · 2005 · 150 citations · Full text

, , +12

Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma

Lanie Francis, Yazan Alsayed, Xavier Leleu et al. · Clinical Cancer Research · 2006 · 91 citations · Full text

, , +14

Preparation of Polyetherol-Appended Sulfur Porphyrazines and Investigations of Peripheral Metal Ion Binding in Polar Solvents

Lori A. Ehrlich, Peter J. Skrdla, Wade Jarrell et al. · Inorganic Chemistry · 2000 · 52 citations

, , +17

1–5 of 11